Reactive granulomatous dermatitis as a paraneoplastic phenomenon

Area of Science:

• Dermatology
• Pathology
• Oncology

Background:

• Reactive granulomatous dermatitis (RGD) encompasses interstitial granulomatous dermatitis (IGD), palisaded neutrophilic and granulomatous dermatitis (PNGD), and interstitial granulomatous drug reaction (IGDR).
• These conditions are frequently associated with autoimmune disorders, medications, and paraneoplastic syndromes.
• RGD typically manifests as symmetrical erythematous papules, plaques, or nodules on specific body areas.

Purpose of the Study:

• To review the clinical and histopathological features of RGD.
• To highlight the association of RGD with systemic diseases, including malignancies.
• To emphasize the importance of RGD as a potential early diagnostic marker.

Main Methods:

• Histopathological examination of skin biopsies.
• Clinical evaluation of patient presentation and distribution of lesions.
• Review of literature on RGD and its associations.

Main Results:

• Histologically, IGD shows interstitial histiocyte and lymphocyte infiltration with multinucleated giant cells.
• IGD can present as a paraneoplastic disease associated with myelodysplastic syndromes, leukemias, and solid tumors.
• Diagnosis relies on integrating histopathology with clinical findings.

Conclusions:

• RGD requires both histopathologic and clinical assessment for accurate diagnosis.
• Treatment involves managing the underlying condition, as corticosteroids only provide symptomatic relief.
• Recognizing RGD as an early indicator of systemic disease, particularly cancer, is vital for timely intervention.